SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001422107-13-000090
Filing Date
2013-07-24
Accepted
2013-07-24 11:43:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 greywolfkvpharma13d.htm SC 13D 239021
  Complete submission text file 0001422107-13-000090.txt   240496
Mailing Address 2280 SCHUETZ ROAD ST. LOUIS MO 63146
Business Address 2280 SCHUETZ ROAD ST. LOUIS MO 63146 3146456600
KV PHARMACEUTICAL CO /DE/ (Subject) CIK: 0000057055 (see all company filings)

IRS No.: 430618919 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-12338 | Film No.: 13982983
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4 MANHATTANVILLE ROAD SUITE 201 PURCHASE NY 10577
Business Address 4 MANHATTANVILLE ROAD SUITE 201 PURCHASE NY 10577 914-251-8200
Greywolf Capital Management LP (Filed by) CIK: 0001304096 (see all company filings)

IRS No.: 542104250 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D